[Favorable development of Hodgkin's disease treated with E 39].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use; HODGKIN'S DISEASE/therapy
Evolution favorable de la maladie de Hodgkin par le E 39.